NATIONAL DRUG ABUSE TREATMENT Clinical Trials Network Directory APRIL 2021 National Institutes of Health U.S. Department of Health and Human Services NATIONAL DRUG ABUSE TREATMENT CLINCAL TRIALS NETWORK The National Drug Abuse Treatment Clinical Trials Network (CTN), a means by which medical and specialty treatment providers, treatment researchers, participating patients, and the National Institute on Drug Abuse (NIDA) cooperatively develop, validate, refine, and deliver new treatment options to patients. This unique partnership enables the following: · Conducting studies of behavioral, pharmacological, and integrated behavioral and pharmacological treatment interventions of therapeutic effect in rigorous, multisite clinical trials to determine effectiveness across a broad range of treatment settings and diversified patient populations; and · Ensuring the transfer of research results to physicians, clinicians, providers, and patients. The CTN framework consists of NIDA, multiple Research Nodes, a Clinical Coordinating Center, and a Data and Statistics Center. This framework provides a broad and powerful infrastructure for the rapid, multisite testing and delivery of promising science-based therapies to patients in a variety of treatment settings nationwide. For more information, visit the CTN website at www.drugabuse.gov/CTN. Nodes APPALACHIAN NODE Regional Research and Training Centers Principal Investigators University of Pittsburgh Jane Liebschutz, M.D., M.P.H., FACP Pittsburgh, Pennsylvania Email:
[email protected] West Virginia University Judith Feinberg, M.D., FACP, FIDSA Morgantown, West Virginia Email:
[email protected] BIG SOUTH-WEST NODE Regional Research and Training Center Principal Investigator The University of Texas Madhukar H. Trivedi, M.D. Southwestern Medical Center at Dallas Email:
[email protected] Dallas, Texas University of Texas Health Science Center Jennifer S.